MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis
NASDAQ:MBLY - Nasdaq - US60741F1049 - Common Stock - Currency: USD
Overall MBLY gets a fundamental rating of 4 out of 10. We evaluated MBLY against 81 industry peers in the Automobile Components industry. No worries on liquidiy or solvency for MBLY as it has an excellent financial health rating, but there are worries on the profitability. MBLY is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
MBLY had positive earnings in the past year.
MBLY had a positive operating cash flow in the past year.
In the past 5 years MBLY always reported negative net income.
MBLY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of MBLY (-23.80%) is worse than 90.12% of its industry peers.
Looking at the Return On Equity, with a value of -24.68%, MBLY is doing worse than 83.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.8% | ||
| ROE | -24.68% | ||
| ROIC | N/A |
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 48.25%, MBLY belongs to the top of the industry, outperforming 98.77% of the companies in the same industry.
In the last couple of years the Gross Margin of MBLY has remained more or less at the same level.
MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.25% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
2. Health
2.1 Basic Checks
MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MBLY has more shares outstanding than it did 1 year ago.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 17.50 indicates that MBLY is not in any danger for bankruptcy at the moment.
The Altman-Z score of MBLY (17.50) is better than 98.77% of its industry peers.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 17.5 |
ROIC/WACCN/A
WACC9.02%
2.3 Liquidity
MBLY has a Current Ratio of 7.64. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
MBLY's Current ratio of 7.64 is amongst the best of the industry. MBLY outperforms 96.30% of its industry peers.
MBLY has a Quick Ratio of 6.38. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 6.38, MBLY belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.64 | ||
| Quick Ratio | 6.38 |
3. Growth
3.1 Past
The earnings per share for MBLY have decreased strongly by -33.33% in the last year.
The Revenue has decreased by -0.38% in the past year.
Measured over the past years, MBLY shows a quite strong growth in Revenue. The Revenue has been growing by 13.48% on average per year.
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.29%
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%83.26%
3.2 Future
The Earnings Per Share is expected to grow by 52.12% on average over the next years. This is a very strong growth
MBLY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.85% yearly.
EPS Next Y15.75%
EPS Next 2Y29.19%
EPS Next 3Y34.86%
EPS Next 5Y52.12%
Revenue Next Year5.53%
Revenue Next 2Y10.13%
Revenue Next 3Y15.9%
Revenue Next 5Y23.85%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 40.63, which means the current valuation is very expensive for MBLY.
Based on the Price/Earnings ratio, MBLY is valued a bit more expensive than 74.07% of the companies in the same industry.
MBLY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.25.
The Price/Forward Earnings ratio is 38.95, which means the current valuation is very expensive for MBLY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MBLY indicates a rather expensive valuation: MBLY more expensive than 80.25% of the companies listed in the same industry.
MBLY is valuated expensively when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.63 | ||
| Fwd PE | 38.95 |
4.2 Price Multiples
83.95% of the companies in the same industry are cheaper than MBLY, based on the Enterprise Value to EBITDA ratio.
MBLY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MBLY is more expensive than 71.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.32 | ||
| EV/EBITDA | 115.67 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MBLY's earnings are expected to grow with 34.86% in the coming years.
PEG (NY)2.58
PEG (5Y)N/A
EPS Next 2Y29.19%
EPS Next 3Y34.86%
5. Dividend
5.1 Amount
No dividends for MBLY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.25
-0.13 (-0.79%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners109.34%
Inst Owner Change10.17%
Ins Owners3.55%
Ins Owner Change-0.28%
Market Cap13.20B
Analysts74.12
Price Target19.69 (21.17%)
Short Float %23.47%
Short Ratio5.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.88%
Min EPS beat(2)4.12%
Max EPS beat(2)15.64%
EPS beat(4)4
Avg EPS beat(4)9.55%
Min EPS beat(4)0.46%
Max EPS beat(4)17.98%
EPS beat(8)7
Avg EPS beat(8)11.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.39%
Min Revenue beat(2)-1.33%
Max Revenue beat(2)0.55%
Revenue beat(4)3
Avg Revenue beat(4)0.53%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)1.6%
Revenue beat(8)4
Avg Revenue beat(8)-0.23%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.02%
PT rev (3m)-5.16%
EPS NQ rev (1m)6.23%
EPS NQ rev (3m)25.53%
EPS NY rev (1m)-5.47%
EPS NY rev (3m)-3.22%
Revenue NQ rev (1m)1.93%
Revenue NQ rev (3m)6.98%
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.63 | ||
| Fwd PE | 38.95 | ||
| P/S | 7.12 | ||
| P/FCF | 33.32 | ||
| P/OCF | 28.13 | ||
| P/B | 1.1 | ||
| P/tB | 5.61 | ||
| EV/EBITDA | 115.67 |
EPS(TTM)0.4
EY2.46%
EPS(NY)0.42
Fwd EY2.57%
FCF(TTM)0.49
FCFY3%
OCF(TTM)0.58
OCFY3.55%
SpS2.28
BVpS14.84
TBVpS2.9
PEG (NY)2.58
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.8% | ||
| ROE | -24.68% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.25% | ||
| FCFM | 21.37% |
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
F-Score6
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 14.31% | ||
| Cap/Sales | 3.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 464.36% | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.64 | ||
| Quick Ratio | 6.38 | ||
| Altman-Z | 17.5 |
F-Score6
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)18.23%
Cap/Depr(5y)20.31%
Cap/Sales(3y)5.18%
Cap/Sales(5y)7.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.29%
EPS Next Y15.75%
EPS Next 2Y29.19%
EPS Next 3Y34.86%
EPS Next 5Y52.12%
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%83.26%
Revenue Next Year5.53%
Revenue Next 2Y10.13%
Revenue Next 3Y15.9%
Revenue Next 5Y23.85%
EBIT growth 1Y-115.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.67%
EBIT Next 3Y57.26%
EBIT Next 5Y49.51%
FCF growth 1Y7.77%
FCF growth 3Y-11.23%
FCF growth 5Y4.5%
OCF growth 1Y1.52%
OCF growth 3Y-12.59%
OCF growth 5Y5.92%